Phone: (914) 594 4166
New York Medical College
Basic Sciences Building (BSB), 451
Valhalla, NY 10595
Genomics and Devices – We are interested in the applications of the whole-genome sequencing (WGS) to understand the emergence and dissemination of bacterial and fungal pathogens. We have developed and validated WGS methods and applied deep sequencing to understand infectious disease dynamics. We are passionate about introduction of new diagnostic tests to address the challenges of emerging and re-emerging pathogenic fungi. We aim to promote the adaptation of new technologies by the clinical microbiology laboratories.
Antifungals Drugs – We have a sustained record of productivity in innovation of laboratory testing of antifungal drugs. With support from major pharmaceutical companies, we developed several rapid and sensitive methods for susceptibility testing of antifungals alone and in combination. We have also participated and lead numerous multi-laboratory studies to standardize antifungal susceptibility testing methods for the clinical laboratories.
Epidemiology of Microbial Diseases – We have made several major contributions to molecular epidemiology of fungal and bacterial pathogens in the United States. Many collaborative publications described new laboratory tools, undocumented clinical conditions, and occurrence of pathogens outside of known endemic areas. We lead rapid outbreak investigations, characterizations of unknown pathogens, defined pathogen virulence, and provided a bridge between basic and translational science.
Previous professional positions: New York State Department of Health, California Department of Public Health, and Yale University School of Medicine
Research expertise and interests: rapid diagnostics, antimicrobials, microbial pathogenesis, molecular epidemiology, and bacterial and fungal genomics.
Membership: Editor-in-Chief, Mycopathologia